Logo image of PLAN

Anaplan Inc (PLAN) Stock Fundamental Analysis

NYSE:PLAN - New York Stock Exchange, Inc. - US03272L1089 - Common Stock

63.73  +0.37 (+0.58%)

After market: 63.74 +0.01 (+0.02%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to PLAN. PLAN was compared to 282 industry peers in the Software industry. Both the profitability and financial health of PLAN have multiple concerns. PLAN shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year PLAN has reported negative net income.
PLAN had negative earnings in each of the past 5 years.
In the past 5 years PLAN always reported negative operating cash flow.
PLAN Yearly Net Income VS EBIT VS OCF VS FCFPLAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 -50M -100M -150M -200M

1.2 Ratios

Industry RankSector Rank
ROA -27.06%
ROE N/A
ROIC -60.67%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PLAN Yearly ROA, ROE, ROICPLAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 -20 -40 -60

1.3 Margins

Industry RankSector Rank
OM -35.42%
PM (TTM) -33.25%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PLAN Yearly Profit, Operating, Gross MarginsPLAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 50 -50

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PLAN is destroying value.
Compared to 1 year ago, PLAN has more shares outstanding
PLAN has a better debt/assets ratio than last year.
PLAN Yearly Shares OutstandingPLAN Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 50M 100M
PLAN Yearly Total Debt VS Total AssetsPLAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 200M 400M 600M 800M

2.2 Solvency

PLAN has an Altman-Z score of 9.19. This indicates that PLAN is financially healthy and has little risk of bankruptcy at the moment.
A Debt/Equity ratio of 0.03 indicates that PLAN is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 9.19
ROIC/WACC-8.59
WACC7.06%
PLAN Yearly LT Debt VS Equity VS FCFPLAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 100M 200M 300M

2.3 Liquidity

PLAN has a Current Ratio of 1.08. This is a normal value and indicates that PLAN is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 1.08 indicates that PLAN should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.08
Quick Ratio 1.08
PLAN Yearly Current Assets VS Current LiabilitesPLAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 100M 200M 300M 400M 500M

More info and screens

7

3. Growth

3.1 Past

PLAN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.85%.
The Revenue has grown by 33.31% in the past year. This is a very strong growth!
The Revenue has been growing by 37.50% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-3.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80%
Revenue 1Y (TTM)33.31%
Revenue growth 3Y35.02%
Revenue growth 5Y37.5%
Sales Q2Q%30.3%

3.2 Future

Based on estimates for the next years, PLAN will show a very strong growth in Earnings Per Share. The EPS will grow by 63.38% on average per year.
PLAN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 24.18% yearly.
EPS Next Y44.31%
EPS Next 2Y38.74%
EPS Next 3Y52.89%
EPS Next 5Y63.38%
Revenue Next Year27.86%
Revenue Next 2Y25.85%
Revenue Next 3Y25.19%
Revenue Next 5Y24.18%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
PLAN Yearly Revenue VS EstimatesPLAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
PLAN Yearly EPS VS EstimatesPLAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PLAN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PLAN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PLAN Price Earnings VS Forward Price EarningsPLAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -500 -1K -1.5K -2K

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -47.72
PLAN Per share dataPLAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PLAN's earnings are expected to grow with 52.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.74%
EPS Next 3Y52.89%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PLAN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Anaplan Inc

NYSE:PLAN (6/21/2022, 8:04:00 PM)

After market: 63.74 +0.01 (+0.02%)

63.73

+0.37 (+0.58%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-26 2022-05-26/bmo
Earnings (Next)08-29 2022-08-29
Inst Owners0%
Inst Owner Change0%
Ins Owners1%
Ins Owner Change0%
Market Cap9.59B
Analysts70.77
Price Target69.3 (8.74%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 15.19
P/FCF N/A
P/OCF N/A
P/B 38.94
P/tB N/A
EV/EBITDA -47.72
EPS(TTM)-0.27
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS4.2
BVpS1.64
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.06%
ROE N/A
ROCE N/A
ROIC -60.67%
ROICexc N/A
ROICexgc -69.29%
OM -35.42%
PM (TTM) -33.25%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.08
Quick Ratio 1.08
Altman-Z 9.19
F-Score2
WACC7.06%
ROIC/WACC-8.59
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80%
EPS Next Y44.31%
EPS Next 2Y38.74%
EPS Next 3Y52.89%
EPS Next 5Y63.38%
Revenue 1Y (TTM)33.31%
Revenue growth 3Y35.02%
Revenue growth 5Y37.5%
Sales Q2Q%30.3%
Revenue Next Year27.86%
Revenue Next 2Y25.85%
Revenue Next 3Y25.19%
Revenue Next 5Y24.18%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A